Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries

Fig. 2

BPI scores for “worst pain” severity and “pain interference” by country and for EU5. Higher scores represent greater pain severity/inference. Differences between countries p < 0.001 for both scores (Kruskal–Wallis test). BPI, Brief Pain Inventory; EU5, European Union 5; SD, standard deviation, UK, United Kingdom

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us